CAPABILITIES
Four rooms, deliberately chosen.
Pharmamosaic sits on the commercial side of the value chain — the decisions that shape how an asset reaches the market and performs once it's there. We don't do drug discovery, clinical development, or manufacturing strategy. We focus on the four capability areas where commercial and launch leaders make the decisions that most shape an asset's trajectory, and where the quality of the analysis and the organisational design behind it compounds over years. What follows is a map of what we do, and what sits outside our scope.
Where we work — and where we don't
In scopePharmamosaic focus
01
Commercial Strategy & Launch Readiness
Positioning, segmentation, access, and the organisational design to deliver on them. The work that translates a strategic plan into a launch that holds through the first twelve months post-approval.
Read more →
02
Competitive Intelligence & Scenario Planning
Structured scenario work adapted from Shell's methodology, built for brand teams who need to stress-test decisions under uncertainty. Competitive landscapes, perception mapping, wargaming.
Read more →
03
Opportunity Assessment & Business Development
Clear-eyed valuations and go/no-go analyses for in-licensing, out-licensing, acquisitions, and portfolio decisions. The analysis that becomes the anchor of a negotiation, not a justification after one.
Read more →
04
Organisational Design & Transformation
How the commercial, medical, and access functions need to be structured to deliver the strategy. The organisational answer that most strategy work leaves out.
Read more →
Out of scopeSpecialist firms do this better
—
Drug discovery & target validation
Target selection, chemistry, preclinical biology.
—
Clinical development & operations
Trial design, site selection, clinical execution, CRO management.
—
CMC & manufacturing strategy
Process development, supply chain, tech transfer, scale-up.
Pharmamosaic · Capability map